These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7774627)

  • 1. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.
    Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B
    Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized.
    Vaage JT; Dissen E; Ager A; Fossum S; Rolstad B
    Eur J Immunol; 1991 Sep; 21(9):2167-75. PubMed ID: 1716212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens.
    Vaage JT; Naper C; Løvik G; Lambracht D; Rehm A; Hedrich HJ; Wonigeit K; Rolstad B
    J Exp Med; 1994 Aug; 180(2):641-51. PubMed ID: 8046337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
    Kraus E; Lambracht D; Wonigeit K; Hünig T
    Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell recognition of "self" and "non-self" triggering antigens on normal lymphoblasts.
    Hirayama M; Genyea C; Kaplan J
    Cell Immunol; 1996 Oct; 173(1):33-48. PubMed ID: 8871599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an inhibitory MHC receptor on alloreactive rat natural killer cells.
    Naper C; Ryan JC; Nakamura MC; Lambracht D; Rolstad B; Vaage JT
    J Immunol; 1998 Jan; 160(1):219-24. PubMed ID: 9551974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
    Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
    Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
    Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
    J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity.
    Chadwick BS; Miller RG
    J Immunol; 1992 Apr; 148(7):2307-13. PubMed ID: 1545133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of F1 anti-parental resistance in H-2b/d F1 hybrids devoid of beta2-microglobulin.
    Höglund P; Olsson-Alheim MY; Johansson M; Kärre K; Sentman CL
    Eur J Immunol; 1997 Jan; 27(1):342-5. PubMed ID: 9022038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial NK cell tolerance induced by radioresistant host cells in rats transplanted with MHC-mismatched bone marrow.
    Naper C; Kveberg L; Engh E; Nestvold J; Rolstad B; Vaage JT
    Int Immunol; 2010 Dec; 22(12):973-80. PubMed ID: 21118904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
    Rolstad B; Benestad HB
    Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
    Lobo PI; Spencer CE
    J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of non-RT1 genes in the response of rat lymphocytes to Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin.
    Cole BC; Griffiths MM; Sullivan GJ; Ward JR
    J Immunol; 1986 Apr; 136(7):2364-9. PubMed ID: 3081642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.